New Peptide ETF From REX Looks Beyond GLP-1 Drugs
A new peptide ETF launched today, holding the drugmakers behind GLP-1 weight-loss treatments along with the companies that make and deliver them. Key Takeaways: REX's new fund follows 36 peptide-linked companies, ranging from GLP-1 drugmakers to device and supplement makers.
REX American Resources Corporation (REX) Q2 2027 Earnings Call Transcript
REX American Resources Corporation (REX) Q2 2027 Earnings Call Transcript
REX American Resources Q2 Earnings Call Highlights
REX American Resources NYSE: REX reported record second-quarter earnings per share for fiscal 2026, supported by stronger ethanol margins, improved product pricing and contributions from the Section 45Z production tax credit program.
REX Shares & BMO Launch 3X Leveraged Corporate Bond ETNs
Volatility from shifting Fed expectations and geopolitical events in today's current environment creates an ideal backdrop for active bond traders.
Investing in the Peptide Boom: REX Files for New Peptide ETF
On July 27, REX Shares filed for the REX Peptides ETF tracking the VettaFi Peptides Index. The fund targets companies strategically positioned to advance the development, manufacturing, and commercial adoption of peptide-based products.
Betting on the Backbone: REX Files for AI Chipmaking ETF
Investor demand for AI chip manufacturers has surged this year. The industry is expected to reach revenues of $1.3 trillion in 2026, according to Yahoo Finance, driven by a global AI infrastructure buildout and a bottleneck for AI semiconductors and hardware.
REX Drone ETF Sees Inflows as Defense Spending Climbs
According to ETF Database, the REX Drone ETF (DRNZ) fund attracted approximately $11.28 million in inflows during the first week of the month. An additional $4.6 million arrived on July 7, bringing its five-day net inflows to $15.88 million.
REX Drone ETF DRNZ Glides Past $100 Million AUM Goalpost
The REX Drone ETF (DRNZ) may only have been on the market for less than a year now, but this fund has certainly enjoyed fortuitous momentum in the past few months. Recently, the fund passed the laudable $100 million threshold for assets under management.
REX American Resources Corporation (REX) Q1 2027 Earnings Call Transcript
REX American Resources Corporation (REX) Q1 2027 Earnings Call Transcript
REX American Resources Still Has A Bright Outlook
REX American Resources (REX) has surged 130% in 12 months, driven by strong earnings, tax credits, and favorable industry tailwinds. REX's Q4 FY25 saw gross profit rise 64% and EPS more than quadruple, aided by $28.1M in 45Z tax credits and lower corn costs. The company advances a carbon capture project, positioning for further tax credits and enhanced earnings potential under evolving government policies.
REX American Resources Corporation (REX) Q4 2026 Earnings Call Transcript
REX American Resources Corporation (REX) Q4 2026 Earnings Call Transcript
REX American Resources: A Cautionary Downgrade
REX American Resources is downgraded from 'buy' to 'hold' due to valuation concerns despite a strong historical run. REX maintains a rock-solid balance sheet and continues to invest in growth, including ethanol capacity expansion and carbon capture initiatives. Industry conditions remain challenging with persistently weak ethanol pricing, though export growth and lower corn input costs provide some optimism.
